Viewing Study NCT02245412


Ignite Creation Date: 2025-12-26 @ 10:19 PM
Ignite Modification Date: 2026-02-23 @ 9:52 AM
Study NCT ID: NCT02245412
Status: TERMINATED
Last Update Posted: 2019-01-03
First Post: 2014-09-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host Disease
Sponsor: Alexion Pharmaceuticals, Inc.
Organization: